⌘K

Login Start Free

Home/Filings/4/0001127602-21-000257

4//SEC Filing

Chan Gerald 4

Accession 0001127602-21-000257

CIK 0001492422other

View on SEC.gov Company Profile

Filed

Jan 3, 7:00 PM ET

Accepted

Jan 4, 7:25 PM ET

Size

5.0 KB

Accession

0001127602-21-000257

Insider Transaction Report

Form 4

Period: 2021-01-01

Apellis Pharmaceuticals, Inc.APLS

Director

Transactions

Award
Stock Option (Right to Buy)
2021-01-01+27,600→ 27,600 total
Exercise: $57.20Exp: 2030-12-31→ Common Stock (27,600 underlying)

Footnotes (1)

[F1]This option was granted 01/01/2021. The option vests quarterly over 1 year on the last day of each quarter from grant date

Documents

1 file

4
form4.xmlPrimary
PRIMARY DOCUMENT

Issuer

Apellis Pharmaceuticals, Inc.

CIK 0001492422

Entity typeother

Related Parties

1

filerCIK 0001636579

Filing Metadata

Form type: 4
Filed: Jan 3, 7:00 PM ET
Accepted: Jan 4, 7:25 PM ET
Size: 5.0 KB

View on SEC.gov